Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression

Michelle M. Mielke, Jeannie Marie Leoutsakos, Chris D. Corcoran, Robert C. Green, Maria C. Norton, Kathleen A. Welsh-Bohmer, Joann T. Tschanz, Constantine G. Lyketsos

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences